Skip to main content
Clinical Trials/NCT04890457
NCT04890457
Unknown
Not Applicable

Transcutaneous Vagus Nerve Stimulation Promotes Oxytocin Release and Increases Fixations on Nose

University of Electronic Science and Technology of China1 site in 1 country54 target enrollmentMarch 5, 2021
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
University of Electronic Science and Technology of China
Enrollment
54
Locations
1
Primary Endpoint
Oxytocin release
Last Updated
4 years ago

Overview

Brief Summary

The main aim of the study is to investigate whether the transcutaneous vagus nerve stimulation(tVNS) promotes oxytocin release and the potential biomarkers of tVNS based on eye-tracking data

Detailed Description

A randomized, single-blinded, sham-controlled, within-subject, crossover design will be employed in this study. In a randomized order, a total of 54 healthy subjects will receive transcutaneous vagus nerve stimulation via tragus and sham stimulation vis earlobe in the left ear (interval between these two stimulations will be 1 week). Eye-tracking and behavioral data will be collected before and after 30 minutes of stimulation, saliva samples will be collected before and after 30 minutes of stimulation, and the end of the experiment. Some personal traits will be assessed using different kinds of questionnaires, such as the Autism Spectrum Quotient(ASQ), Social Responsiveness Scale(SRS), State-Trait Anxiety Inventory (STAI), Beck's Depression Inventory(BDI), and Toronto Alexithymia Scale (TAS-20).

Registry
clinicaltrials.gov
Start Date
March 5, 2021
End Date
December 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University of Electronic Science and Technology of China
Responsible Party
Principal Investigator
Principal Investigator

Keith Kendrick

Professor

University of Electronic Science and Technology of China

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects without past or current psychiatric or neurological disorders

Exclusion Criteria

  • history of head injury;
  • pregnant, menstruating, taking oral contraceptives;
  • medical or psychiatric illness.

Outcomes

Primary Outcomes

Oxytocin release

Time Frame: After 30 min tragus stimulation

Investigating the oxytocin release after vagus nerve stimulation via tragus based on saliva samples

Secondary Outcomes

  • The relationship between oxytocin concentration and personal traits(through study completion, an average of half an year)
  • Pupil size(After 30 min tragus stimulation)

Study Sites (1)

Loading locations...

Similar Trials